B. D. Agnis, D. S. Berman, D. Spicehandler, W. El-sadr, M. S. Simberkoff et al., Effect of Combined Therapy with Ansamycin, Clofazimine, Ethambutol, and Isoniazid for Mycobacterium avium Infection in Patients with AIDS, Journal of Infectious Diseases, vol.159, issue.4, pp.784-787, 1989.
DOI : 10.1093/infdis/159.4.784

E. J. Baron and L. S. Young, Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndrome, Diagnostic Microbiology and Infectious Disease, vol.5, issue.3, pp.215-220, 1986.
DOI : 10.1016/0732-8893(86)90004-0

W. W. Barrow, E. L. Wright, K. S. Goh, and N. Rastogi, Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium avium., Antimicrobial Agents and Chemotherapy, vol.37, issue.4, pp.652-661, 1993.
DOI : 10.1128/AAC.37.4.652
URL : https://hal.archives-ouvertes.fr/pasteur-00925364

S. Bazile, N. Moreau, D. Bouzard, and M. Essiz, Relationships among antibacterial activity, inhibition of DNA gyrase, and intracellular accumulation of 11 fluoroquinolones., Antimicrobial Agents and Chemotherapy, vol.36, issue.12, pp.2622-2627, 1992.
DOI : 10.1128/AAC.36.12.2622

L. E. Bermudez, C. B. Inderlied, P. Klonoski, M. Wu, L. Barabara-burnham et al., Activities of Bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice, Antimicrob . Agents Chemother, vol.40, pp.546-551, 1996.

J. Chiu, J. Nussbaum, S. Bozettz, J. G. Tilles, L. S. Young et al., Treatment of Disseminated Mycobacterium avium Complex Infection in AIDS with Amikacin, Ethambutol, Rifampin, and Ciprofloxacin, Annals of Internal Medicine, vol.113, issue.5, pp.358-361
DOI : 10.7326/0003-4819-113-5-358

K. P. Fu, S. C. Lafredo, B. Foleno, D. M. Isaacson, J. F. Barett et al., In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin., Antimicrobial Agents and Chemotherapy, vol.36, issue.4, pp.860-866, 1992.
DOI : 10.1128/AAC.36.4.860

S. D. Goodwin, H. A. Gallis, A. T. Chow, F. A. Wong, S. C. Flor et al., Pharmacokinetics and safety of levofloxacin in patients with human immunodeficiency virus infection., Antimicrobial Agents and Chemotherapy, vol.38, issue.4, pp.799-804, 1994.
DOI : 10.1128/AAC.38.4.799

I. Hayakawa, S. Atarashi, S. Yokohama, M. Imamura, K. Sakano et al., Synthesis and antibacterial activities of optically active ofloxacin., Antimicrobial Agents and Chemotherapy, vol.29, issue.1, pp.163-164, 1986.
DOI : 10.1128/AAC.29.1.163

L. B. Heifets and P. J. Lindholm-levy, Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against mycobacterium tuberculosis and mycobacterium avium complex, Tubercle, vol.68, issue.4, pp.267-276, 1987.
DOI : 10.1016/0041-3879(87)90067-5

J. Hoy, A. Mijch, M. Sandland, L. Grayson, R. Lucas et al., Quadruple-Drug Therapy for Mycobacterium avium-intracellulare Bacteremia in AIDS Patients, Journal of Infectious Diseases, vol.161, issue.4, pp.801-805, 1990.
DOI : 10.1093/infdis/161.4.801

M. Immamura, S. Shibamura, I. Hayakawa, and Y. Osada, Inhibition of DNA gyrase by optically active ofloxacin., Antimicrobial Agents and Chemotherapy, vol.31, issue.2, pp.325-327, 1987.
DOI : 10.1128/AAC.31.2.325

B. Ji, N. Lounis, C. Truffot-pernot, and J. Grosset, In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosis, Antimicrobial Agents and Chemotherapy, vol.39, issue.6, pp.1341-1344, 1995.
DOI : 10.1128/AAC.39.6.1341

S. P. Klemens, C. A. Sharpe, M. C. Rogge, and M. H. Cynamon, Activity of levofloxacin in a murine model of tuberculosis., Antimicrobial Agents and Chemotherapy, vol.38, issue.7, pp.1476-1479, 1994.
DOI : 10.1128/AAC.38.7.1476

N. Mor, J. Vanderkolk, and L. Heifets, Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages., Antimicrobial Agents and Chemotherapy, vol.38, issue.5, pp.1161-1164, 1994.
DOI : 10.1128/AAC.38.5.1161

M. Nakashima, T. Uematsu, M. Kanamura, O. Okazaki, S. Hashimoto et al., Pharmacokinetics of DR-3355, a new quinolone, in healthy volunteers, abstr. 951, p. 278, Program and abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1988.

H. C. Neu and N. Chin, In vitro activity of S-ofloxacin., Antimicrobial Agents and Chemotherapy, vol.33, issue.7, pp.1105-1107, 1989.
DOI : 10.1128/AAC.33.7.1105

A. Pascual, I. Garcia, and E. J. Perea, Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes., Antimicrobial Agents and Chemotherapy, vol.33, issue.5, pp.653-656, 1990.
DOI : 10.1128/AAC.33.5.653

A. Pascual, I. Garcia, and E. J. Perea, Uptake and intracellular activity of an optically active ofloxacin isomer in human neutrophils and tissue culture cells., Antimicrobial Agents and Chemotherapy, vol.34, issue.2, pp.277-280, 1990.
DOI : 10.1128/AAC.34.2.277

N. Rastogi, Mycobacteria as intracellular pathogens: current notions of pathogenicity, virulence, and drug resistance and their relation to effective therapy Antimicrobial agents and intracellular pathogens, pp.245-300, 1993.

M. Reddy, H. Denis, J. L. Shiratsuchi, J. J. Johnson, J. T. Ellner et al., 11th Forum in Microbiology. Laboratory and clinical aspects of the Mycobacterium avium epidemic: contributing factors associated with variability of drug susceptibility and immune responsiveness, and the multifaceted nature of pathogenicity, Res. Microbiol, vol.145, pp.167-261, 1994.

N. Rastogi, K. S. Goh, and A. Bryskier, In vitro activity of roxithromycin against 16 species of atypical mycobacteria and effect of pH on its radiometric MICs., Antimicrobial Agents and Chemotherapy, vol.37, issue.7, pp.1560-1562, 1993.
DOI : 10.1128/AAC.37.7.1560
URL : https://hal.archives-ouvertes.fr/pasteur-00925365

N. Rastogi, K. S. Goh, and A. Bryskier, Activities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complex., Antimicrobial Agents and Chemotherapy, vol.38, issue.6, pp.1433-1438, 1994.
DOI : 10.1128/AAC.38.6.1433
URL : https://hal.archives-ouvertes.fr/pasteur-00925370

N. Rastogi and V. Labrousse, Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex., Antimicrobial Agents and Chemotherapy, vol.35, issue.3, pp.462-470, 1991.
DOI : 10.1128/AAC.35.3.462

N. Rastogi, V. Labrousse, and A. Bryskier, Intracellular activities of roxithromycin used alone and in association with other drugs against Mycobacterium avium complex in human macrophages, Antimicrobial Agents and Chemotherapy, vol.39, issue.4, pp.976-978, 1995.
DOI : 10.1128/AAC.39.4.976
URL : https://hal.archives-ouvertes.fr/pasteur-00925375

N. Rastogi, V. Labrousse, K. S. Goh, J. P. Carvalho, and . Sousa, Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages., Antimicrobial Agents and Chemotherapy, vol.35, issue.12, pp.2473-2480, 1991.
DOI : 10.1128/AAC.35.12.2473

H. Saito, K. Sato, H. Tomioka, and S. Dekio, In vitro antimycobacterial activity of a new quinolone, levofloxacin (DR3355), Tubercle and Lung Disease, vol.76, issue.5, pp.377-380, 1995.
DOI : 10.1016/0962-8479(95)90001-2

P. S. Skinner, S. K. Furney, D. A. Kleinert, and I. A. Orme, Comparison of activities of fluoroquinolones in murine macrophages infected with Mycobacterium tuberculosis, Antimicrobial Agents and Chemotherapy, vol.39, issue.3, pp.750-753, 1995.
DOI : 10.1128/AAC.39.3.750

M. Tanaka, M. Otsuki, T. Une, and T. Nishino, In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacin, Journal of Antimicrobial Chemotherapy, vol.26, issue.5, pp.659-666, 1990.
DOI : 10.1093/jac/26.5.659

P. M. Tulkens, Intracellular distribution and activity of antibiotics, European Journal of Clinical Microbiology & Infectious Diseases, vol.29, issue.Supplement D, pp.100-106, 1991.
DOI : 10.1007/BF01964420

T. Une, T. Fujimoto, K. Sato, and Y. Osada, In vitro activity of DR-3355, an optically active ofloxacin., Antimicrobial Agents and Chemotherapy, vol.32, issue.9, pp.1336-1340, 1988.
DOI : 10.1128/AAC.32.9.1336